Cargando…
Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible factor-1α in non-small cell lung cancer A549 cells
Lung cancer is one of the most frequently occurring and fatal cancer types worldwide. Cisplatin is widely used for chemotherapy of non-small cell lung cancer (NSCLC). However, the use of cisplatin has been met with the challenge of chemoresistance as a result of hypoxia, which is common in adult sol...
Autores principales: | Guo, Qiang, Lan, Fei, Yan, Xu, Xiao, Zhu, Wu, Yuelei, Zhang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019907/ https://www.ncbi.nlm.nih.gov/pubmed/29971135 http://dx.doi.org/10.3892/ol.2018.8767 |
Ejemplares similares
-
Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α
por: Mao, Xiawa, et al.
Publicado: (2021) -
Hypoxia-inducible transcription factor-1α promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway
por: Luo, FengMing, et al.
Publicado: (2006) -
Role of hypoxia-inducible factor-1α in autophagic cell death in microglial cells induced by hypoxia
por: Wang, Xintao, et al.
Publicado: (2017) -
Wheatgrass Extract Ameliorates Hypoxia-induced Mucin Gene Expression in A549 cells
por: Sim, Ju hwan, et al.
Publicado: (2017) -
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
por: Deben, Christophe, et al.
Publicado: (2018)